Ieq Capital »

Lineage Cell Therapeutics In shares owned by Ieq Capital

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Ieq Capital from 13F filings

Historical chart of Ieq Capital investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Ieq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Ieq Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $271k 160k 1.69
2025-06-30 $21k 23k 0.91

More positions owned by Ieq Capital

Applovin Corp Com Cl A (APP)
Roblox Corp Cl A (RBLX)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Vanguard Index Fds Total Stk Mkt (VTI)
Crowdstrike Hldgs Cl A (CRWD)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Snowflake Com Shs (SNOW)

View all positions for Ieq Capital

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Raffles Associates
Brian McDonald
Millennium Management
Geode Capital Management
BlackRock
Renaissance Technologies
Dauntless Investment Group
State Street Corporation
Morgan Stanley
GSA Capital Partners
Red Crane Wealth Management
Northern Trust
Eudaimonia Asset Management

View all funds holding Lineage Cell Therapeutics In